Nomenclature	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=444	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=445	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=446	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=447
HGNC, UniProt	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:4571, http://www.uniprot.org/uniprot/P42261	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:4572, http://www.uniprot.org/uniprot/P42262	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:4573, http://www.uniprot.org/uniprot/P42263	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:4574, http://www.uniprot.org/uniprot/P48058
Agonists	(http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4070, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4131	(http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4070, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4131	(http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4070, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4131	(http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4070, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4131
Selective antagonists	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4141, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4209, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4210 (active isomer, non‐competitive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4264, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4245	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4141, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4209, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4210 (active isomer, non‐competitive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4264, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4245	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4141, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4209, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4210 (active isomer, non‐competitive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4264, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4245	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4141, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4209, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4210 (active isomer, non‐competitive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4264, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4245
Channel blockers	extracellular http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4138, extracellular http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4229 (selective for channels lacking GluA2)	extracellular http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4138	extracellular http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4138, extracellular http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4229 (selective for channels lacking GluA2)	extracellular http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4138, extracellular http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4229 (selective for channels lacking GluA2)
Allosteric modulators	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4248 (Positive) (pEC50 5.8) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4249 (Positive) (pEC50 5.2) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4167 (Positive) (pEC50 4.7) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4165 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4166 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4219 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4251 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4304 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4133 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4288 (Positive)	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4249 (Positive) (pEC50 6.8) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4248 (Positive) (pEC50 6.7) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4167 (Positive) (pEC50 5.7) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4165 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4166 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4219 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4251 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4304 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4133 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4288 (Positive)	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4249 (Positive) (pEC50 5.8) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4248 (Positive) (pEC50 5.7) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4167 (Positive) (pEC50 4.9) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4165 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4166 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4219 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4251 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4304 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4133 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4288 (Positive)	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4248 (Positive) (pEC50 6.7) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4249 (Positive) (pEC50 6.7) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4167 (Positive) (pEC50 5.4) [http://www.ncbi.nlm.nih.gov/pubmed/11406188?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4165 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4166 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4219 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4251 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4304 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4133 (Positive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4288 (Positive)
Labelled ligands	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4077 (Agonist), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4081 (Antagonist)	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4077 (Agonist), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4081 (Antagonist)	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4077, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4081	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4077 (Agonist), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4081
Comments	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4288 and http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4133 are examples of pyrrolidinones. http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4167, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4304, and http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4219 are examples of benzothiadiazides. http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4165 and http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4166 are examples of benzylpiperidines. http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4248, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4249 and http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4251 are examples of biarylpropylsulfonamides. Also blocked by intracellular polyamines.